Clinical trial
Evaluating a Non-Opioid Analgesic Strategy for Enhanced Recovery After Total Knee Arthroplasty: A Randomized Controlled Trial of Suzetrigine
NCT07357376 is registered in ClinicalTrials.gov with AdventHealth as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating a Non-Opioid Analgesic Strategy for Enhanced Recovery After Total Knee Arthroplasty: A Randomized Controlled Trial of Suzetrigine
- Lead sponsor
- AdventHealth
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- March 1, 2026
- Completion date
- August 1, 2026
- Enrollment
- 210 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative pain following knee arthroplasty